Cisen Pharmaceutical Co Ltd
603367
Company Profile
Business description
Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.
Contact
Tongji Sci-tech Industrial Park
High-tech Industrial Development Zone
Shandong
Jining272073
CHNT: +86 5372980071
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
3,114
Stocks News & Analysis
stocks
Chart of the Week: Recent selloffs in this ASX sector opens doors to opportunity
Ongoing rate hikes have investors spooked.
stocks
ASX dividend champions: Stocks, ETFs and LICs
Mark and Shani run through lessons for ASX stocks, ETFs and LICs that have delivered over the past decade.
stocks
SpaceX’s IPO filing: Big spending, big losses
The first public financials from Elon Musk’s company highlight Starlink’s revenue power and increased spending on AI.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,856.30 | 6.00 | 0.07% |
| CAC 40 | 8,117.42 | 135.66 | 1.70% |
| DAX 40 | 24,737.24 | 336.59 | 1.38% |
| Dow JONES (US) | 50,009.35 | 645.47 | 1.31% |
| FTSE 100 | 10,432.34 | 101.79 | 0.99% |
| HKSE | 25,620.58 | 30.54 | -0.12% |
| NASDAQ | 26,270.36 | 399.65 | 1.54% |
| Nikkei 225 | 61,945.34 | 2,140.93 | 3.58% |
| NZX 50 Index | 12,803.41 | 42.38 | 0.33% |
| S&P 500 | 7,432.97 | 79.36 | 1.08% |
| S&P/ASX 200 | 8,635.50 | 7.50 | 0.09% |
| SSE Composite Index | 4,174.79 | 12.61 | 0.30% |